期刊文献+

cTnI在急性冠脉综合征早期诊断中的临床研究 被引量:3

The clinical study of cTnI in the early diagnosis of acute coronary syndrome
暂未订购
导出
摘要 目的评价心肌标志物肌钙蛋白I(cTnI)快速定量检测系统在急性冠脉综合征早期诊断的准确性和省时性,为尽早进行介入治疗赢得时间。方法本研究采用随机、自身对照的试验设计。对符合入选标准的150例患者采取血样,分别进行cTnI快速定量检测和实验室常规心肌酶检测,观察与比较两种检测结果及得出结果时间。结果 cTnI快速定量检测与实验室心肌酶检测结果的准确性一致,但cTnI快速定量检测明显快于实验室常规检测。结论 cTnI快速定量检测系统有利于急性冠脉综合征的早期诊断。 Objective To evaluate the myocardial markers troponinI ( cTnI ) rapid quantitative detection system in the early diagnosis of acute coronary syndrome. Methods This study used a randomized and controlled trial design. The blood samples of eligible patients were tested respectively by eTnI rapid quantitative detection and laboratory detection of myocardial enzymes, observation and comparison between the test results and the time. Results The accuracy of cTnI rapid quantitative detection and laboratory detection of myocardial enzymes of was consistent, but the cTnI rapid quantita- tive detection was significantly faster than the laboratory detection. Conclusion cTnI rapid quantitative detection system is helpful for early diagnosis of acute coronary syndrome.
作者 姜文
出处 《西部医学》 2012年第11期2138-2139,共2页 Medical Journal of West China
关键词 CTNI 急性冠脉综合征 诊断 cTnI Acute coronary syndrome Diagnosis
  • 相关文献

参考文献5

二级参考文献15

  • 1Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics-2007 update: a report from the American Heart Association statistics committee and stroke statistics committee [J]. Circulation, 2007,115(5) :69-171.
  • 2Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-STelevation myocardial infarction-executive summary[J]. J Am Coll Cardiol, 2007,50 (8) : 652-726.
  • 3Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarctionexecutive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction) [ J ]. Circulation, 2004,110(5 ) : 282- 292.
  • 4Smith SC, Feldman TE, Hirshfeld JW, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary inter-venfion: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCM Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention) [J]. Circulation,2006,113(7) : 166-286.
  • 5Levine GN, Berger PB, Cohen DJ, et al. Newer pharmacotherapy in patients undergoing percutaneous coronary interventions: a guide for pharmacists and other health care professionals expert opinion from the American Heart Association's Diagnostic and Interventional Catheterization Committee and Council on Clinical Cardiology, and the American College of Clinical Pharmacy' s Cardiology Practice Research Network [J]. Pharmacotherapy, 2006,26 ( 11 ) : 1537-1556.
  • 6Grines CL, Bonow RO, Casey DE, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, Ameri-can College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians [J]. Cireulation,2007,115(6) :813-818.
  • 7Smith SC, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update[J]. J Am Coll Cardiol,2006,47(10): 2130-2139.
  • 8Ryden L, Standl E, Bartnik M, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular disease: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)[J]. Eur Heart J,2007,28(1):88-136.
  • 9Krumholz HM, Anderson JL, Brooks NH, et al. ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/ American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-Elevation Myocardial Infarction)[J]. J Am Coll Cardiol, 2006, 47(1) :236-265.
  • 10Raphael See MD,James A. Lemos MD. Current status of risk stratification methods in acute coronary syndromes[J] 2006,Current Cardiology Reports(4):282~288

共引文献4

同被引文献10

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部